$0.528
+0.035 (+6.60%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
APRE 相似图表分析预测
Alphio's APRE stock price prediction model matches the current Aprea Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.52 (-1.10%). The 1-week path is $0.52 (-2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Aprea Therapeutics Inc 股票吗?
Aprea Therapeutics Inc is a good buy right now due to its recent price increase of 8.96% over the last five days, indicating positive momentum. The stock's current price is $0.53, which is significantly below its 52-week high of $1.49, suggesting potential for upside. Additionally, the company has a strong cash position of $46.5 million as of March 31, 2026, which is expected to sustain operations until Q1 2028, reducing financial risk. However, the main risk is the ongoing negative earnings trend, with a reported EPS of -0.09 in the last quarter, which reflects continued losses.
APRE 股价于 Friday 收于 $0.53,此前上涨 +6.60%
Aprea Therapeutics Inc (APRE) last closed at $0.528, gaining +6.60%. These facts feed the 1-day and 1-week APRE price prediction above.
预测驱动因素
Aprea Therapeutics Inc(APRE)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 APRE 最接近的股票,按相似度排序。
APRE 季节性分析
Historically the probability of a positive November return for APRE is 0.00%. January offers the highest probability of a positive month at 80.33%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
相关文章
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。